Results 11 to 20 of about 692,791 (244)

Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure

open access: yesPatient Preference and Adherence, 2016
Catherine Girouard,1–3 Jean-Pierre Grégoire,1–3 Paul Poirier,2,4 Jocelyne Moisan1–3 1Chair on Adherence to Treatments, Université Laval, 2Faculty of Pharmacy, Université Laval, 3Population Health and Optimal Health
Girouard C   +3 more
doaj   +1 more source

Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease

open access: yesInternational Journal of COPD, 2017
Naohiro Oda,1 Nobuaki Miyahara,1,2 Hirohisa Ichikawa,3 Yasushi Tanimoto,4 Kazuhiro Kajimoto,5 Makoto Sakugawa,6 Haruyuki Kawai,7 Akihiko Taniguchi,1 Daisuke Morichika,1 Mitsune Tanimoto,1 Arihiko Kanehiro,1 Katsuyuki Kiura1 1Department of Allergy and ...
Oda N   +11 more
doaj   +1 more source

Impact of Beta‐Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population‐Based Cohort Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundRelevant clinical studies have been small and have not convincingly demonstrated whether the perioperative initiation of beta‐blockers should be considered in patients with diabetes mellitus undergoing noncardiac surgery.
Ray‐Jade Chen   +2 more
doaj   +1 more source

Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression. [PDF]

open access: yesPLoS ONE, 2018
Stroke-induced immunodepression is a well characterized complication of acute ischemic stroke. In experimental studies beta-blocker therapy reversed stroke-induced immunodepression, reduced infection rates and mortality.
Ilko L Maier   +6 more
doaj   +1 more source

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist [PDF]

open access: yes, 2013
Nebivolol, a third generation β-adrenoceptor (β-AR) antagonist (β-blocker), causes vasodilation by inducing nitric oxide (NO) production. The mechanism via which nebivolol induces NO production remains unknown, resulting in the genesis of much of the ...
Jackson, Edwin K.   +36 more
core   +1 more source

Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients

open access: yesCardiovascular Diabetology, 2019
Background Although beta blockers could increase the risk of hypoglycemia, the difference between subtypes on hypoglycemia and mortality have not been studied.
Kathleen Dungan   +3 more
doaj   +1 more source

Evaluation of central: peripheral blood pressure ratio in patients undergoing coronary angiography: A pilot study from North India

open access: yesHeart India, 2020
Aim: The study aimed to propose the ratio of central blood pressure:peripheral blood pressure as a novel index to predict cardiovascular risk. We additionally attempted to determine the impact of beta-blocker therapy on this ratio. Materials and Methods:
Sharad Chandra   +4 more
doaj   +1 more source

An Update on the Use of Molecularly Imprinted Polymers in Beta-Blocker Drug Analysis as a Selective Separation Method in Biological and Environmental Analysis

open access: yesMolecules, 2022
Beta-blockers are antihypertensive drugs and can be abused by athletes in some sport competitions; it is therefore necessary to monitor beta-blocker levels in biological samples.
Aliya Nur Hasanah   +2 more
doaj   +1 more source

Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. [PDF]

open access: yesPLoS ONE, 2015
BACKGROUND:Infections are a frequent cause for prolonged hospitalization and increased mortality after stroke. Recent studies revealed a stroke-induced depression of the peripheral immune system associated with an increased susceptibility for infections.
Ilko L Maier   +4 more
doaj   +1 more source

Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis

open access: yesClinical Medicine Insights: Endocrinology and Diabetes, 2022
Background: Depression is associated with lower quality of life and increased risk of mortality. The prevalence of depression in chronic dialysis patients, as well as in patients with diabetes, is more than 20%. It is debated whether use of beta-blockers
Robin Lengton   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy